Inventor

Shiv Srivastava

Inventor
Potomac, MD, US

Overview

17→
Patents
2003–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 17 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides23%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
A61KPreparations for medical, dental or toiletry purposes10%
C12NMicroorganisms or enzymes8%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
C07CAcyclic or carbocyclic compounds3%
C07DHeterocyclic compounds3%
C09BOrganic dyes or closely-related compounds for producing dyes, e.g. pigments3%
H05KPrinted circuits3%
PatentTitleYear
10,711,311Genomic rearrangements associated with prostate cancer and methods of using the same202010,287,587Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations201910,238,639Azophenols as ERG oncogene inhibitors201910,081,842Prostate cancer gene expression profiles201810,066,268Methods of diagnosing or treating prostate cancer using the ERG gene, alone or in combination with other over or under expressed genes in prostate cancer20189,868,993'Methods of diagnosing or treating prostate cancer using the ERG gene, alone or in combination with other over or under expressed genes in prostate cancer'20189,782,394'Inhibitors for ERG oncogene positive cancers'20179,464,325'Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer'20169,347,101'Methods of diagnosing or treating prostate cancer using the ERG gene, alone or in combination with other over or under expressed genes in prostate cancer'20169,335,327'Isolation and detection of cancer cells'20169,206,481'Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations'20158,765,916'ERG monoclonal antibodies'20148,541,169'Prostate cancer-specific alternations in ERG gene expression and detection and treatment methods based on those alterations'20137,807,373'Prostate specific gene, PCGEM1, and methods of using PCEGM1 to detect, treat, and prevent prostate cancer'20107,537,896'Androgen-regulated PMEPA1 gene and polypeptides'20096,828,429'Prostate-specific gene, PCGEM1, and the methods of using PCGEM1 to detect, treat, and prevent prostate cancer'20046,566,130'Androgen-regulated gene expressed in prostate tissue'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2016Patents assigned to JACKSON H M FOUND MILITARY MED (9)· patent assignee history
2003–2020Based in Potomac, MD, US· patent location history
2013–2018Patents assigned to PETROVICS GYORGY (5)· patent assignee history
2013–2018Patents assigned to SRIVASTAVA SHIV (5)· patent assignee history
2013–2015Patents assigned to DOBI ALBERT (3)· patent assignee history
2016–2020Patents assigned to HENRY M JACKSON FOUND ADVANCEMENT MILITARY MEDICINE INC (8)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JACKSON H M FOUND MILITARY MED92003–2016
HENRY M JACKSON FOUND ADVANCEMENT MILITARY MEDICINE INC82016–2020
PETROVICS GYORGY52013–2018
SRIVASTAVA SHIVself52013–2018
DOBI ALBERT32013–2015
Locations
LocationPatentsSpan
Potomac, Maryland, US172003–2020